Synergy Pharma (SGYP) – FDA News
-
Synergy Pharma (SGYP) Highlights New Analyses Supporting Use of TRULANCE (plecanatide) in Two Patient Populations
-
Synergy Pharma (SGYP) Enters License Agreement with Luoxin for TRULANCE in China
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SGYP Stock Lookup